News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Raykov Rosty
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/03/2023 |
4
| Raykov Rosty (CEO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 175,000 options to buy
@ $8.32, valued at
$1.5M
Granted 87,500 options to buy
@ $0 |
|
| 12/30/2022 |
4
| Raykov Rosty (CEO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Sold 13,740 shares
@ $9.59, valued at
$131.8k
Sold 5,000 shares
@ $9.65, valued at
$48.3k
Sold 1,600 shares
@ $9.6586, valued at
$15.5k
Sold 8,400 shares
@ $9.6135, valued at
$80.8k
|
|
| 09/12/2022 |
4
| Raykov Rosty (CEO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Exercised 16,666 options to buy
@ $0.72, valued at
$12k
|
|
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Raykov Rosty (CEO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Exercised 323,961 shares
@ $1.85, valued at
$599.3k
Paid exercise price by delivering 97,136 shares
@ $6.17, valued at
$599.3k
Paid exercise price by delivering 37,931 shares
@ $5.77, valued at
$218.9k
Paid exercise price by delivering 38,013 shares
@ $5.68, valued at
$215.9k
Paid exercise price by delivering 12,093 shares
@ $5.71, valued at
$69.1k
|
|
| 05/15/2020 |
4
| Raykov Rosty (CEO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 250,000 options to buy
@ $6.93, valued at
$1.7M
|
|
| 04/08/2019 |
4
| Raykov Rosty (CEO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 150,000 options to buy
@ $4.83, valued at
$724.5k
|
|
| 08/22/2018 |
4/A
| Raykov Rosty (CEO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Exercised 17,050 shares
@ $1.44, valued at
$24.6k
|
|
| 08/21/2018 |
4
| Raykov Rosty (CEO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Exercised 17,050 shares
@ $1.44, valued at
$24.6k
|
|
| 02/08/2018 |
4
| Raykov Rosty (CEO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 100,000 options to buy
@ $8.38, valued at
$838k
|
|
| 09/20/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/17/2009 |
3
| Form 3 -- Initial statement of beneficial ownership of securities |
|
|